SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-008313
Filing Date
2017-05-08
Accepted
2017-05-08 17:17:11
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20170331_10q.htm 10-Q 1255936
2 EXHIBIT 10.4 ex10-4.htm EX-10.4 66904
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 10104
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 10444
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 7959
  Complete submission text file 0001437749-17-008313.txt   4900035

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS acrx-20170331.xml EX-101.INS 946176
7 EXHIBIT 101.SCH acrx-20170331.xsd EX-101.SCH 53050
8 EXHIBIT 101.CAL acrx-20170331_cal.xml EX-101.CAL 34641
9 EXHIBIT 101.DEF acrx-20170331_def.xml EX-101.DEF 285760
10 EXHIBIT 101.LAB acrx-20170331_lab.xml EX-101.LAB 263711
11 EXHIBIT 101.PRE acrx-20170331_pre.xml EX-101.PRE 302658
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 17823443
SIC: 2834 Pharmaceutical Preparations